secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2026-07-02T20:00:15+00:00
Accession:  0001193125-26-294445
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CMS withdraws Medicare billing changes for Orthofix bone growth stimulators; reimbursement restored to prior rates
--------------------------------------------------------------------------------

- On July 1, 2026, CMS issued revised guidance withdrawing May 18, 2026 billing changes for HCPCS codes E0747, E0748, E0760.
- Orthofix expects average Medicare reimbursement for these codes to return to rates in effect prior to May 18, 2026.
- The reversal follows FDA's April 16, 2026 reclassification of non-invasive bone growth stimulators from Class III to Class II.
- The prior CMS changes had modified billing requirements and Medicare fee schedule treatment; now withdrawn.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312526294445/0001193125-26-294445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312526294445/ofix-20260701.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-294445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer